TE_193
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | AluY |
|---|---|
| TE superfamily | Alu |
| TE class | SINE |
| Gene | AKR7L |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 0.78 |
| Counts of samples | TCGA_tumor:97; TCGA_normal:20; GTEx:121 |
| TSS | chr1(-):19271362 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_193.1 | AKR7L | Chimeric | Non-coding | Non-coding | chr1(-):19267441,19267461,19268572,19268701,19270451,19270555,19270748,19270935,19271191,19271363 |
| teRNA_193.2 | AKR7L | Chimeric | Non-coding | Non-coding | chr1(-):19267441,19267461,19268572,19268701,19269272,19269371,19269583,19269679,19270451,19270555,19270748,19270935,19271191,19271363 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
